ANDA 86712, held by Alpharma US Pharms. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 86712 (Chlorpromazine Hydrochloride), held by Alpharma US Pharms, was first approved by FDA on Nov 10, 1980, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 10, 1980 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride10MG/5ML ยท syrup;oral | Chlorpromazine Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters